JFJennifer A. Fidler

Jennifer A. Fidler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jennifer A. Fidler has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    'The smoking toolkit study': a national study of smoking and smoking cessation in England

    by Jennifer A Fidler, Lion Shahab, Oliver West, Martin J Jarvis, Andy McEwen, John A Stapleton, Eleni Vangeli, Robert West

    Up-to-date data tracking of national smoking patterns and cessation-related behaviour is required to evaluate and inform tobacco control strategies. The Smoking Toolkit Study (STS) was designed for this role. This paper describes the methodology of the STS and examines as far as possible the representativeness of the samples. The STS consists of monthly, cross sectional household interviews of adults aged 16 and over in England with smokers and recent ex-smokers in each monthly wave followed up by postal questionnaires three and six months later. Between November 2006 and December 2010 the baseline survey was completed by 90,568 participants. STS demographic, prevalence and cigarette consumption estimates are compared with those from the Health Survey for England (HSE) and the General Lifestyle Survey (GLF) for 2007-2009. Smoking prevalence estimates of all the surveys were similar from 2008 onwards (e.g 2008 STS = 22.0%, 95% C.I. = 21.4% to 22.6%, HSE = 21.7%, 95% C.I. = 20.9% to 22.6%, GLF = 20.8%, 95% C.I. = 19.7% to 21.9%), although there was heterogeneity in 2007 (chi-square = 50.30, p < 0.001). Some differences were observed across surveys within sociodemographic sub-groups, although largely in 2007. Cigarette consumption was virtually identical in all surveys and years. There is reason to believe that the STS findings (see http://www.smokinginengland.info ) are generalisable to the adult population of England.


  • Variation in saliva cotinine as a function of self-reported attempts to reduce cigarette consumption

    by Jennifer A. Fidler, John A. Stapleton, Robert West

    Cotinine is an accurate objective marker of nicotine intake. There is very little information on its stability over time or as a function of self-reported attempts at smoking reduction.


  • Did the Introduction of Varenicline in England Substitute for or Add to the Use of Other Smoking Cessation Medications?

    by Daniel Kotz, Jennifer A. Fidler, Robert West

    Varenicline has recently been added to the market as a new drug for smoking cessation. The aim of the current study was to assess whether varenicline substituted for, or added to, the use of other smoking cessation medications. We used data from 2,595 smokers taking part in monthly household surveys of representative samples of the English population. We analyzed the percentage of smokers attempting to quit in the past 3 months and using nicotine replacement therapy over the counter (NRT OTC), NRT on prescription (NRT Rx), bupropion, or varenicline from November 2006 to December 2009. This survey covered 3 periods: (a) after the launch of varenicline but before the publication of the National Institute of Health and Clinical Excellence guidance on varenicline in July 2007, (b) the first year following the guidance, and (c) more than 1 year after the guidance. Varenicline usage was negligible in the first period, increased steadily during the second period, and increased less rapidly in the third period to 5.3% of those making a quit attempt (p < .001 for the trend). The percentage of quit attempters using any smoking cessation medication increased nonsignificantly by 2.8 percentage points from 41.7% to 44.5% (p = .268). The use of NRT OTC decreased significantly by 6.2 percentage points from 35.2% to 29.0% (p = .029), whereas the use of NRT Rx increased significantly by 3.7 percentage points from 6.8% to 10.5% (p = .025), and use of bupropion remained unchanged. Increased use of varenicline in England following guidance from the National Institute for Clinical Excellence in 2007 did not appear to substitute for use of other prescription smoking cessation medication. An observed decline in NRT OTC is likely to have been due to other factors.


  • Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components

    by Jennifer A Fidler, Lion Shahab, Robert West

    Aims  Measuring the strength of urges to smoke during a normal smoking day among smokers in a culture where smoking is restricted could provide a good measure of the severity of cigarette dependence. An important criterion for a measure of cigarette dependence is how well it predicts failure of attempts to stop smoking. This study compared ratings of Strength of Urges to Smoke (SUTS) with the Fagerström Test of Nicotine Dependence (FTND) and its components, including the Heaviness of Smoking Index (HSI).Design  A longitudinal study involving a household survey of a representative sample of adult smokers at baseline and 6‐month follow‐up by postal questionnaire.Setting  England.Participants  A total of 15 740 smokers aged 16 and over underwent the baseline interview; 2593 were followed‐up 6 months later, of whom 513 reported having made a quit attempt following the baseline survey but at least 1 month prior to the follow‐up.Measurements  SUTS, FTND, HSI, cigarettes per day, time to first cigarette, age, social grade and gender were measured at baseline. Quit attempts since the baseline assessment and self‐reported abstinence were measured at 6‐month follow‐up.Findings  In logistic regressions, all dependence measures predicted success of subsequent quit attempts, but SUTS had the strongest association (beta for SUTS, FTND and HSI: 0.41: P < 0.001, 0.13: P = 0.005, and 0.19: P = 0.003, respectively). In multiple logistic regressions when SUTS was entered as a predictor of abstinence, together with other dependence measures, it remained as the only predictive dependence measure.Conclusions  A simple rating of strength of urges on a normal smoking day appears to be a good predictor of at least short‐term quit success in English smokers and as such may be a useful measure of cigarette addiction.


  • Changes in smoking prevalence in 16–17‐year‐old versus older adults following a rise in legal age of sale: findings from an English population study

    by Jennifer A. Fidler, Robert West

    Aim  To assess smoking prevalence before and after the rise in legal age of sale of cigarettes in England and Wales from age 16 to age 18 in October 2007.Design  A series of monthly cross‐sectional household surveys: the ‘Smoking Toolkit Study’.Setting  England.Participants  A total of 53 322 adults aged 16 and over interviewed between October 2006 and May 2009, 1136 of whom were aged 16 or 17 years.Measurements  Change in smoking prevalence from pre‐ to post‐legislation, assessed by self‐reported smoking status, among the 16–17‐year‐old group and older adults.Findings  The prevalence change following the legislation among those aged 16 and 17 was 7.1 percentage points (denominator = 1136) compared with 2.4 percentage points (denominator = 52 186) for older adults (odds ratio 1.36, P = 0.024, 95% confidence interval = 1.04–1.77 for the interaction). There was no difference within older age categories.Conclusions  There was a greater fall in prevalence in 16–17‐year‐olds following an increase in age of sale than in older age groups. This provides some support to the view that raising the age of sale can, at least in some circumstances, reduce smoking prevalence in younger age groups.


  • Self-perceived smoking motives and their correlates in a general population sample

    by Jennifer A. Fidler, Robert West

    Understanding motivation to continue smoking may help the development of smoking cessation interventions. However, little information exists on the prevalence of specific motives for smoking in representative samples of smokers. This study examined smokers’ reports of their motives for continued smoking in an English general population sample. A total of 2,133 smokers participating in monthly cross-sectional surveys (the Smoking Toolkit Study) identified which, if any, of the following motives they believed were important in keeping them smoking: enjoyment, stress relief, weight control, boredom relief, aid to concentration, aid to socializing, pain relief, liking being a smoker, and feeling bad when not smoking. Associations between these motives and gender, age, social grade, Fagerström Test for Nicotine Dependence, and quit attempts in the last year were examined using logistic regression. Enjoyment and stress relief were the most commonly reported motives (51% and 47%, respectively). Women reported stress relief and weight control more often than men, whereas men were more likely to report enjoyment and liking being a smoker. Older smokers reported enjoying smoking and liking being a smoker more than younger smokers but were less likely to report socializing and stress relief as important motives. Not having made a quit attempt in the last year was associated with enjoying smoking and liking being a smoker. Higher dependence was associated with a greater number of reported motives. While smoking for stress relief is common, perceptions of enjoyment of smoking and positive smoker identity may be the key motives that inhibit attempts at cessation.


  • Open Access

    Nicotine Intake in Cigarette Smokers in England: Distribution and Demographic Correlates

    by Jennifer A. Fidler, Martin J. Jarvis, Jennifer Mindell, Robert West

    Documenting smoke intake by objective biochemical markers is important for quantification of exposure to toxins. The aim of this report is to show the most definitive distribution of the nicotine metabolite, cotinine, yet available from English smokers in the period before implementation of the legislation banning smoking in indoor public areas. A total of 6,423 cigarette smokers, ages 16 years and above, taking part in the Health Survey for England between 1998 and 2003 provided a saliva cotinine value. Data on cigarette consumption, age, gender, social class, deprivation (as indicated by manual or nonmanual occupation, car ownership, and housing tenure), marital status, and region were collected. Cotinine concentrations showed no overall trend over the study period. The mean value was 289.15 ng/mL (SD 174.43); excluding those who had not smoked in the past 24 hours, the mean value was 302.08 ng/mL (SD 168.78). A higher cotinine concentration was associated with being middle-aged (peaking at 40 years), being male, being single, greater economic deprivation, and not living in London. After adjusting for cigarette consumption, higher values were associated with middle age, being male, and greater deprivation. This study provides the most complete picture yet of the smoke intake of cigarette smokers in England. The fact that cotinine peaks at around the age of 40 years raises the possibility that nicotine intake continues to increase decades after a person starts to smoke. Greater nicotine intake in more deprived smokers could explain why they find it harder to stop smoking. (Cancer Epidemiol Biomarkers Prev 2008;17(12):3331–6)


  • Smoking status of step‐parents as a risk factor for smoking in adolescence

    by Jennifer A. Fidler, Robert West, Cornelia H. M. Van Jaarsveld, Martin J. Jarvis, Jane Wardle

    Aim To examine the extent to which smoking by step‐parents and biological parents predicts adolescent smoking. Design Five‐year cohort study. Setting Thirty‐six schools in South London, England. Participants A subset of 650 students participating in the Health and Behaviour In Teenagers Study (HABITS), who reported living in step‐families, were assessed annually from age 11–12 to age 15–16 years. Measurements Students reported their smoking status, which was cotinine‐verified, as well as whether their parents smoked and, if they lived with a step‐parent, whether that step‐parent smoked. Analyses also controlled for gender, ethnicity and deprivation. Findings Students who reported that just their step‐parent smoked at age 11–12 were significantly more likely to report current smoking at any time‐point from age 11–16 than those who reported having neither biological parents nor a step‐parent who smoked [odds ratio (OR) 2.72, 95% confidence interval (CI) = 1.36–5.47], as were those with both a parent and a step‐parent who smoked (OR 2.23, 95% CI = 1.46–3.41). While the association between smoking in students and smoking in biological parents in this subsample did not reach statistical significance (OR 1.39, 95% CI = 0.88–2.19), these students were no more or less likely to smoke than those with just a step‐parent who smoked. Conclusion Smoking by a non‐biological parent appears at least as influential as smoking by biological parents. This confirms the importance of social influence on smoking initiation and suggests that attempts to work with parents in smoking prevention should involve, and perhaps pay particular attention to, step‐parents who smoke.


  • Does smoking in adolescence affect body mass index, waist or height? Findings from a longitudinal study

    by Jennifer A. Fidler, Robert West, Cornelia H. M. Van Jaarsveld, Martin J. Jarvis, Jane Wardle

    Aim To assess the effect of smoking uptake on body mass index (BMI), waist circumference and height during adolescence. Design Five‐year longitudinal study. Setting Thirty‐six schools in South London, England, selected by a stratified random sampling procedure designed to ensure ethnic and socio‐economic diversity. Participants A total of 5863 students took part in the HABITS (Health and Behaviour in Teenagers) Study between 1999 and 2003. Measurements Self‐reported smoking behaviour, saliva cotinine concentrations and measured weight, waist circumference and height were obtained, along with information on gender, ethnicity, socio‐economic deprivation, pubertal status, self‐reported exercise and dieting. Students were examined annually from school year 7 (ages 11–12) to year 11 (ages 15–16), with response rates ranging from 74 to 84%. A total of 2665 never smokers at year 7 with complete data for years 7 and 11 were included in the analyses. Findings Adjusting for year 7 BMI and other potential confounders, regular smokers (more than six cigarettes a week) at year 11 had significantly lower BMI (P = 0.002) than other students. Smokers defined by a cotinine above 15 ng/ml also had lower BMI (P < 0.0001). Waist circumferences were lower in regular smokers (P = 0.014) and cotinine‐defined smokers (P < 0.011). No consistent association was found between smoking and height. The adjusted difference in weight between regular smokers and other students amounted to 1.8 kg (95% CI, 0.52–3.17) for an average‐height student. Conclusion Taking up regular smoking during adolescence may result in a lower BMI, but the effect is small and of uncertain significance.